PHARNEXT SA appointed Dr. Elisabeth Svanberg MD, PhD to succeed Michel de Rosen as Chairman of the Board of Directors effective January 1st, 2022. Michel de Rosen has served as Chairman of the Board since June 2016 and will continue to serve as a Non-Executive Director. Dr. Svanberg has extensive experience in the development of novel treatments across therapeutic areas.